Viral infection during pregnancy has been correlated with increased frequency of autism spectrum disorder (ASD) in offspring. This observation has been modeled in rodents subjected to maternal immune activation (MIA). The immune cell populations critical in the MIA model have not been identified. Using both genetic mutants and blocking antibodies in mice, we show that retinoic acid receptor-related orphan nuclear receptor gamma t (RORgt)-dependent effector T lymphocytes [for example, T helper 17 (T H 17) cells] and the effector cytokine interleukin-17a (IL-17a) are required in mothers for MIA-induced behavioral abnormalities in offspring. We find that MIA induces an abnormal cortical phenotype, which is also dependent on maternal IL-17a, in the fetal brain. Our data suggest that therapeutic targeting of T H 17 cells in susceptible pregnant mothers may reduce the likelihood of bearing children with inflammation-induced ASD-like phenotypes.
S
everal studies have suggested that viral infection of women during pregnancy correlates with an increased frequency of autism spectrum disorder (ASD) in the offspring (1) (2) (3) (4) (5) (6) . In the rodent maternal immune activation (MIA) model of this phenomenon (7), offspring from pregnant mice infected with virus or injected intraperitoneally with synthetic doublestranded RNA (dsRNA) [poly(I:C)], a mimic of viral infection, exhibit behavioral symptoms reminiscent of ASD: social deficits, abnormal communication, and repetitive behaviors (8) . T helper 17 (T H 17) cells are responsible for immune responses against extracellular bacteria and fungi, and their dysregulation is thought to underlie numerous inflammatory and autoimmune diseases (9) , such as asthma, rheumatoid arthritis, psoriasis, inflammatory bowel disease (IBD), and multiple sclerosis. The transcription factor retinoic acid receptor-related orphan nuclear receptor gamma t (RORgt) is expressed in several cell types in the immune system. It is a key transcriptional regulator for the development of T H 17 cells, as well as gd T cells and innate lymphoid cells (such as ILC3) that express T H 17 cell-like cytokines, in both humans and mice (10) (11) (12) (13) .
T H 17 cells and their cytokine mediators have been suggested to have a role in ASD. For example, elevated levels of interleukin-17a (IL-17a), the predominant T H 17 cytokine, have been detected in the serum of a subset of autistic children (14, 15) . A genome-wide copy number variant (CNV) analysis identified IL17A as one of many genes enriched in autistic patients (16) . Similarly, in the MIA mouse model, CD4 + T lymphocytes from affected offspring produced higher levels of IL-17a upon in vitro activation (17, 18) . Although these data suggest that T H 17 cells may be involved in ASD patients, whether T H 17 cells are the specific immune cell population that is necessary for MIA phenotypes is unknown. Here, we show that maternal RORgtexpressing proinflammatory T cells, a major source of IL-17a, are required in the MIA model for induction of ASD-like phenotypes in offspring. Consistent with this notion, antibody blockade of IL-17a activity in pregnant mice protected against the development of MIAinduced behavioral abnormalities in the offspring. Also, we found atypical cortical development in affected offspring, and this abnormality was rescued by inhibition of maternal T H 17-IL-17a pathways.
Elevated fetal brain IL-17Ra mRNA follows increased maternal IL-17a in MIA Pregnant mothers injected with poly(I:C) on embryonic day 12.5 (E12.5) had strong induction of serum cytokines IL-6, tumor necrosis factor-a (TNF-a), interferon-b (IFN-b), and IL-1b at 3 hours, compared with phosphate-buffered saline (PBS)-injected control dams (Fig. 1A and fig. S1 , A to C). Additionally, poly(I:C) injection resulted in a strong increase of serum IL-17a at E14.5 (Fig.  1B) . On the other hand, poly(I:C) did not affect the levels of the anti-inflammatory cytokine IL-10 in the serum nor in placenta and decidua extracts ( fig. S1D) . It was previously shown that the proinflammatory effector cytokine IL-6, a key factor for T H 17 cell differentiation (19) , is required in pregnant mothers for MIA to produce ASD-like phenotypes in the offspring (7) . We found that poly(I:C) injection into pregnant dams lacking IL-6 [IL-6 knockout (KO)] failed to increase the serum levels of IL-17a at E14.5, consistent with IL-6 acting upstream of IL-17a. Conversely, recombinant IL-6 injections into wild-type (WT) mothers were sufficient to induce IL-17a levels comparable to those of poly(I:C)-injected WT mothers ( fig.  S1E ). Placenta-and decidua-associated mononuclear cells, isolated from poly(I:C)-treated animals at E14.5 and cultured for 24 hours, expressed amounts of IL-6 mRNA similar to those of PBS controls (Fig. 1C) . In contrast, IL-17a mRNA expression in these cells was strongly up-regulated by poly(I:C) injection (Fig. 1D ). This increase in mRNA expression was correlated with enhanced secretion of IL-17a by placenta-and decidua-associated mononuclear cells from poly(I:C)-treated dams (Fig. 1E) , upon ex vivo stimulation with phorbolmyristate acetate (PMA) and ionomycin, which mimics T cell receptor (TCR) activation. IL-17a induction was specific to the placenta and decidua, as small intestine mononuclear cells from poly(I:C)-treated pregnant dams did not secrete more IL-17a than those from PBS-treated controls ( fig. S1F ).
We also observed that expression of the IL-17a receptor subunit A (IL-17Ra) mRNA, but not subunit C (IL-17Rc) mRNA, was strongly augmented in the fetal brain upon induction of MIA (Fig. 1, F and G). By in situ hybridization, IL-17Ra mRNA was detected in the mouse cortex, and its expression was strongly up-regulated in E14.5 fetal brains after poly(I:C) injection of pregnant dams (Fig. 1, H and I ). The in situ probe detecting endogenous expression of IL-17Ra was specific, as it did not produce detectable signal in E14.5 fetal brain that lacks IL-17Ra ( fig. S2 ).
Maternal IL-17a promotes abnormal cortical development in offspring
We next investigated if pathological activation of the IL-17 pathway in pregnant mothers affects fetal brain development and subsequently contributes to the ASD-like behavioral phenotypes in offspring. To test this hypothesis, we pretreated pregnant mothers with isotype control or IL-17a-blocking antibodies before injecting them with PBS or poly(I:C) ( fig. S3 ). We then examined cortical development in the fetus for the following reasons: (i) Poly(I:C) injection of mothers increases IL-17Ra expression in the cortex of the fetal brain (Fig. 1, H and I) ; (ii) cortical development starts at about E11 (20) , which aligns well with the time points of potential fetal exposure to MIA (7); (iii) disorganized cortex and focal patches of abnormal laminar cytoarchitecture have been found in the brains of ASD patients (21, 22) ; and (iv) MIA has been shown to affect cortical development (23, 24) . We analyzed cortical lamination, an orderly layered structure of the cortex, in fetal brains at E14.5 and E18.5, as well as in the adult brain, using antibodies specific for proteins expressed in the cortex in a layer-specific manner (25) : special AT-rich sequence-binding protein 2 (SATB2) (26) , T-brain-1 (TBR1) (27) , and chicken ovalbumin upstream promoter transcription factor-interacting protein 2 (CTIP2) (28) . MIA led to delayed expression of SATB2 at E14.5 compared with fetuses of control animals (Fig. 2, A and C) . At E18.5, MIA resulted in a patch of disorganized cortical cytoarchitecture (Fig. 2, B and D to G) but did not affect cortical thickness of the fetal brains (Fig. 2H) . This singular patch of disorganized cortex occurred at a similar medial-lateral position in a majority of E18.5 fetal brains (Fig. 2 , E and G) derived from mothers injected with poly(I:C) but not those injected with PBS. The abnormal expression patterns of SATB2, TBR1, and CTIP2 were maintained in adult MIA offspring ( fig. S4 ). Note that normal expression of these cortical layer-specific markers, as well as laminar cortical organization, were largely preserved in the offspring of poly(I:C)-injected mothers pretreated with IL-17a-blocking antibody (Fig. 2, A to D, and fig. S4 ).
Pretreatment with IL-17a-blocking antibody also suppressed the MIA-mediated increase in IL-17Ra mRNA expression in fetal brain at E14.5 (Fig. 1F ). This suppression was accompanied by a reduction in maternal serum IL-17a (Fig. 1B) , which indicated that the up-regulation of IL-17Ra mRNA in fetal brains requires maternal IL-17a signaling. Of note, IL-17a antibody blockade of the IL-17a-IL-17Ra signaling pathway did not result in a concomitant increase of the serum IL-10 levels, and IL-17a mRNA expression was not detected in fetal brain at E14.5, regardless of poly(I:C) injection. Together, these data demonstrate that the maternal IL-17a-dependent pathway mediates disorganized cortical phenotypes in offspring after in utero MIA and suggest that this may be due to exposure of the fetus and its brain to increased levels of IL-17a.
Maternal IL-17a promotes ASD-like behavioral abnormalities in offspring
We next tested the functional relevance of the maternal IL-17a pathway for MIA-induced ASDlike behavioral abnormalities in offspring ( fig.   S3 ). We first assessed MIA offspring for abnormal communication by measuring pup ultrasonic vocalization (USV) responses (29) . After separation from mothers, pups from poly(I:C)-injected mothers pretreated with immunoglobulin G (IgG) isotype control antibody emitted more USV calls than those from PBS-injected mothers (Fig. 3A ), in agreement with previous studies (29, 30) . Some studies have reported reduced USV calls upon MIA (8, 31) , but these opposite effects may reflect differences in methodological approaches, including dose and number of exposures to poly(I:C), as well as timing of poly(I:C) administration. Altogether, these results indicate that MIA induces abnormal USV in offspring. Pretreating poly(I:C)-injected mothers with IL-17a-blocking antibody resulted in offspring that emitted a similar number of USV calls as the pups from PBS-injected control mothers (Fig. 3A) , which demonstrated that IL-17a-mediated signaling events are necessary for the MIA-induced abnormal USV phenotype. As previously reported (7, 8) , we found that prenatal exposure to MIA also caused social interaction deficits in adult offspring (Fig. 3B ). This defect was fully rescued in offspring from poly(I:C)-injected mothers pretreated with IL-17a-blocking antibody (Fig. 3B) . Repetitive and perseverative behaviors are another core feature in ASD that we tested next in our experimental mice using the marble-burying assay (32) . Offspring from poly (I:C)-injected mothers displayed enhanced marble burying compared with offspring from PBSinjected mothers (Fig. 3C) , consistent with previous studies (7, 29) . Pretreatment with IL-17a-blocking antibody of poly(I:C)-injected mothers rescued marble-burying behavior in the offspring (Fig. 3C) . Notably, distinct behavioral phenotypes SCIENCE sciencemag.org 26 observed among different treatment groups were not due to differences in activity or arousal, as total distances moved during the sociability test were indistinguishable (Fig. 3D) . Moreover, different treatment groups displayed comparable gender ratios, litter sizes, and weights ( fig. S5 ). Taken together, these data indicate that the IL-17a pathway in pregnant mice is crucial in mediating the MIA-induced behavioral phenotypes in offspring. RORgt expression in maternal T cells is required for ASD-like phenotypes in the MIA offspring. As RORgt is a critical regulator of the IL-17a pathway (13), we next investigated the role of maternal RORgt in MIA-induced behavioral phenotypes in offspring. Note that T H 17 cells and IL-17a have been detected in the decidua, as well as in the serum, during pregnancy in humans (33) (34) (35) . CD45 + mononuclear cells, including CD4 + T cells, isolated from placenta and decidua of immuneactivated WT mothers, but not from immuneactivated mothers lacking both RORgt and the closely related RORg isoform (RORg KO), produced IL-17a upon ex vivo activation with PMA and ionomycin ( fig. S6, A and B) . Cells isolated from WT and RORg KO mice secreted similar amounts of IFN-g, consistent with the specific effect of RORgt on IL-17a expression ( fig. S6C ). In line with this observation, poly(I:C) treatment increased placenta-and decidua-associated T H 17, but not regulatory T, cells in pregnant dams, compared with PBS treatment (fig. S6, D and E) . RORg KO mice lack RORg and gt expression not only in CD4 + T cells but also in other lymphoid and nonimmune system cells, and they have defective development of secondary and tertiary lymphoid organs (36, 37) . To determine whether RORgt function specifically in T cells mediates MIAinduced phenotypes, we bred RORgt FL animals ( fig. S7 ) to CD4-Cre mice to selectively inactivate rorc(t) in the T cells of pregnant mothers (RORgt TKO) (38) . In these animals, the functions of T H 17 cells (CD4 + RORgt + cells) and other RORgtexpressing abT cells are inhibited, but there is no effect in RORgt-expressing innate (or innatelike) immune cells, including gdT, lymphoid tissueinducer cells, and ILC3 cells (11, 12) , as well as in RORg-expressing nonlymphoid cells. We found that RORgt TKO mothers failed to produce IL17a even after poly(I:C) injection ( fig. S6F ). Note that poly(I:C)-induced malformation of the cortex was prevented in offspring from RORgt TKO mothers (Fig. 4, A and B) , similar to the results from anti-IL-17a treatment (Fig. 2, B and D) . Moreover, we found that prenatal exposure to MIA increased USV calls in pups derived from WT or RORgt heterozygous (HET) mothers, but offspring of RORgt TKO mothers had normal USV behavior (Fig. 4C) . T cell-specific deletion of maternal RORgt also abrogated the MIA-induced social interaction deficit and excessive marble burying in offspring (Fig. 4, D and E) . These results were not due to general activity defects in the offspring of WT, RORgt HET or TKO mothers (Fig. 4F ). Because these offspring were derived from mating RORgt WT, HET and TKO female with WT male mice, they all carried at least one copy of functional RORgt. Therefore, the rescue of MIA-induced phenotypes observed in the offspring of RORgt TKO mothers was not likely due to the lack of T H 17 cells in the offspring. Taken together, these data indicate that maternal CD4 + T lymphocytes expressing RORgt (i.e., T H 17 cells) are necessary for the MIA-mediated expression of cortical abnormalities and three ASD-like behaviors modeled in mouse offspring.
IL-17a administration to the fetal brain promotes abnormal cortical development and ASD-like behavioral phenotypes To determine whether IL-17a acts on receptors in the mother or the fetus to induce the MIA phenotype, we injected poly(I:C) into IL-17Ra WT, HET, or KO mothers that had been bred to IL-17Ra WT or HET males (39) . Removing one or both copies of il17ra in the mother was sufficient to rescue the MIA-induced sociability deficit in offspring, regardless of their genotypes ( fig. S8A) . Moreover, we found that reduced expression of maternal IL-17Ra in il17ra HET mothers led to reduced serum IL-17a in poly(I:C)-treated mothers ( fig. S8B) . Thus, it is difficult, if not impossible, to test the functional significance of the IL-17Ra in offspring with a full germline il17ra KO without affecting maternal T H 17 cell activity. To circumvent this problem, we asked if increasing IL-17Ra activity in the offspring, by introducing IL-17a directly into the fetal brain in the absence of maternal inflammation, would be sufficient to induce MIA phenotypes. Injection of recombinant IL-17a protein into the ventricles of the fetal brain at E14.5 in the absence of MIA (Fig. 5A) led to the appearance of disorganized cortical patches in a similar location to those induced by MIA (Fig. 5,  B to E). Unlike poly(I:C) injection, however, intraventricular injection of IL-17a resulted in thinned cortical plates at the medial but not lateral part of the brain (fig. S9 ). This effect may reflect SCIENCE sciencemag.org 26 differences in the levels or types of inflammation associated with poly(I:C) versus IL-17a injections or the time points at which poly(I:C) (E12.5) and IL-17a (E14.5) were administered. We also found that, compared with sham injection, IL-17a injections led to an enhanced USV phenotype, social approach deficit, and increased marble-burying behavior, all similar in magnitude to those observed in MIA-exposed offspring (Fig. 5, F to H) . These behavioral abnormalities were not due to group differences in mobility (Fig. 5I) . Neither cortical disorganization nor enhanced USV phenotypes were observed after IL-17a injections into the ventricles of IL-17Ra KO fetuses or upon IL-6 injections into WT fetal brains ( fig. S10, A to C) , which suggests that IL-17a, but not IL-6, acts directly in the fetal brain to induce these phenotypes. Of note, in agreement with previous reports (7, 40) , IL-6 injection into pregnant WT mothers was sufficient to produce MIA-associated behavioral (enhanced USV) and cortical phenotypes in the offspring ( fig. S10, D to F ). Yet, pretreatment of pregnant mothers with IL-17a-blocking antibody prevented the phenotypes induced by maternal IL-6 injection ( fig. S10, D to F) . Last, IL-17a injection into brains of fetuses from poly(I:C)-injected IL-6 KO mothers was sufficient to elicit increased pup USVs compared with PBS-injected controls ( fig. S10G ). These data collectively demonstrate that activation of the IL-17Ra pathway in the fetal brain, induced by intraventricular injection of IL-17a into the fetus or by intraperitoneal injection of poly(I:C) or IL-6 into pregnant mothers, results in MIA-associated phenotypes in the offspring.
Therapeutic treatment with IL-17a-blocking antibody in pregnant dams ameliorates MIA-associated behavioral abnormalities Our results suggest that pathological activation of the T H 17 cell-IL-17a pathway during gestation in mothers with some inflammatory conditions may alter fetal brain development and contribute to the ASD-like behavioral phenotypes in offspring ( fig. S11) . T H 17 cells require RORgt for their differentiation and exert their functions by secreting multiple cytokines, including IL17a. Abrogation of RORgt expression in maternal ab T cells or blockade of the IL-17a pathway in pregnant dams resulted in the complete rescue of cortical developmental abnormalities and ASDlike behavioral phenotypes in offspring in the MIA rodent model. Thus, RORgt and T H 17 cells (as well as their cytokines) may serve as good therapeutic targets to prevent the development of ASD phenotypes in the children of susceptible mothers. To further test this idea, we administered IL-17a-blocking antibody to pregnant mice in a time window after MIA induction (Fig. 6A) . We injected pregnant mothers with PBS or poly(I:C) at E12.5, followed by injection of IgG isotype control or IL-17a-blocking antibody at E14.5, when the delayed expression of SABT2 manifests in MIA-exposed fetal brains (Fig. 2, A and C) . Compared with PBS injection followed by control antibody treatment, poly(I:C) injection followed by IL-17a-blocking antibody administration partially rescued USV and marble-burying phenotypes (Fig. 6, B and D) . However, MIA-induced social interaction deficits were not corrected (Fig.   6C ). These effects were not due to group differences in mobility (Fig. 6E) . Thus, treating pregnant mothers with IL-17a-blocking antibody after MIA can correct some of the ASD-like features, but pretreatment with this antibody may have greater therapeutic potential.
Conclusions
Our results identify a specific maternal immune cell population that may have direct roles in inducing ASD-like phenotypes by acting on the developing fetal brain. These findings raise the possibility that modulation of the activity of a cytokine receptor, IL-17Ra, in the central nervous system can influence neuronal development, with implications as to specification of neuronal cell types and their connectivity. Furthermore, note that the loss of certain genes that induce ASD-like phenotypes were also found in mice with defects in cortical lamination (41, 42) . These observations raise the possibility that some genetic and environmental factors that have roles in the etiology of ASD function by way of similar physiological pathways. A related question is whether IL17Ra signaling has a normal physiological function in the fetal and adult brain, especially given the structural similarities observed between the IL-17 family cytokines and neurotrophin proteins (e.g., nerve growth factor) (43, 44) . Elucidating further downstream pathways of maternal IL-17a-producing T cells, both in MIA mothers and their offspring, will likely yield a better understanding of the mechanisms by which inflammation in utero contributes to the development of neurodevelopmental disorders, such as ASD, and, additionally, may provide insights into the roles of cytokine receptors in the central nervous system.
